EUVIMEDEUVIMED entdecken
Open Access

Hospitalization Costs of Kidney Transplantation Associated With Induction Therapy Among Pediatric Kidney Transplant Recipients: A North American Pediatric Renal Trials and Collaborative Studies and Pediatric Health Information System Collaborative Study

Nancy M Rodig iD, Daniella Levy Erez iD, Helen P Pizzo iD, Troy Richardson iD, Michael J Somers iD

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Nancy M Rodig und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Hospitalization, Hospital Costs. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Ancillary Study Grant Program of the North American Pediatric Renal Trials and collaborative Studies (NAPRTCS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Choice of induction agent at the time of pediatric kidney transplantation is primarily influenced by recipient characteristics and center practice. The economic implications of this choice have not been reported in a pediatric cohort.

Methods

This is a retrospective study of merged data from North American Pediatric Renal Trials and Collaborative Studies transplant registry with data in the Pediatric Health Information Systems. We estimated costs of the kidney transplant admission analyzed for association with induction agent and clinical factors. Participants were grouped by induction agent: interleukin‐2 receptor blocker (IL2RB), anti‐thymocyte globulin (ATG), and alemtuzumab. We also estimated inpatient care and other hospital‐based services during the first year after transplantation.

Results

A total of 831 children and young adults < 21 years who received a kidney transplant between January 2010 through 2019 were identified. Among these, 50.5% received ATG, 31.3% received IL2RB only, and 18.2% received alemtuzumab. Among clinical characteristics studied, sex and likelihood of pre‐emptive transplant were similar among the groups. Though unadjusted index hospitalization costs (IHC) were significantly different among the induction groups, induction choice was not associated with IHC in multivariable analysis. Younger age at the time of transplantation and delayed graft function (DGF) were independently associated with higher IHC. Unadjusted hospital‐based costs incurred after discharge from the transplant procedure through the first year after transplantation were similar among induction groups.

Conclusion

Among pediatric and young adult kidney transplant recipients, IHC was comparable across induction agents. Younger age at transplantation and DGF were associated with significantly higher IHC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsHospitalizationHospital CostsHumansFemaleChildMaleRetrospective StudiesAdolescentAlemtuzumabChild, PreschoolYoung AdultAntilymphocyte SerumInfantNorth AmericaRegistriesReceptors, Interleukin-2

Stichwörter der Autor:innen

costshospitalizationkidney transplantationpediatric

Substanzen

Immunosuppressive AgentsAlemtuzumabAntilymphocyte SerumReceptors, Interleukin-2

Autor:innen und Institutionen

  • Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Institute of Nephrology, Schneider Children's Medical Center, Petah Tiqua, Israel.
  • Department of Pediatrics, Cedars-Sinai Guerin Children's, Los Angeles, California, USA.
  • Children's Hospital Association, Lenexa, Kansas, USA.

ORCID-Profile: Nancy M Rodig, Daniella Levy Erez, Helen P Pizzo, Troy Richardson, Michael J Somers

Förderung

  • The Ancillary Study Grant Program of the North American Pediatric Renal Trials and collaborative Studies (NAPRTCS)

Zitieren

APA

Rodig, N. M., Erez, D. L., Pizzo, H. P., Richardson, T., & Somers, M. J. (2026). Hospitalization Costs of Kidney Transplantation Associated With Induction Therapy Among Pediatric Kidney Transplant Recipients: A North American Pediatric Renal Trials and Collaborative Studies and Pediatric Health Information System Collaborative Study. Pediatric Transplantation. https://doi.org/10.1111/petr.70441

Vancouver

Rodig NM, Erez DL, Pizzo HP, Richardson T, Somers MJ. Hospitalization Costs of Kidney Transplantation Associated With Induction Therapy Among Pediatric Kidney Transplant Recipients: A North American Pediatric Renal Trials and Collaborative Studies and Pediatric Health Information System Collaborative Study. Pediatric Transplantation. 2026. doi:10.1111/petr.70441

BibTeX
@article{Rodig2026,
  author = {Rodig, Nancy M and Erez, Daniella Levy and Pizzo, Helen P and Richardson, Troy and Somers, Michael J},
  title = {Hospitalization Costs of Kidney Transplantation Associated With Induction Therapy Among Pediatric Kidney Transplant Recipients: A North American Pediatric Renal Trials and Collaborative Studies and Pediatric Health Information System Collaborative Study},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70441}
}
Kostenlos starten →